Stay updated on Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now includes a new entry: Revision: v3.3.3. The footer link 'HHS Vulnerability Disclosure' and the older 'Revision: v3.3.2' have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T13:33:17.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Record History shows a new metadata revision (Revision: v3.3.2) added and an older revision (Revision: v3.2.0) removed; this reflects version metadata rather than content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T18:27:39.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    - Removed a prominent notice stating that information on the site may not be up to date due to government funding lapses and that the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov for status updates.
    Difference
    0.3%
    Check dated 2025-11-17T18:02:50.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The Record History for NCT03631199 now shows additional history entries, reflecting newer submissions and status updates.
    Difference
    0.0%
    Check dated 2025-11-03T12:34:16.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to operating status information, signaling potential delays in processing and inquiries. - Updated version to v3.2.0 and removed the previous v3.1.0 reference.
    Difference
    7%
    Check dated 2025-10-05T16:44:54.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Update to page version and study-status/locations; old version and revision removed. New v3.1.0 with date 2025-09-22; previous v3.0.2 and date 2025-09-10 removed.
    Difference
    0.8%
    Check dated 2025-09-28T10:07:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.